This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cytheris. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Pierre Cortez: Innovator in Immunology
Introduction
Pierre Cortez is a notable inventor based in Paris, France. He has made significant contributions to the fields of immunology and molecular biology. His work focuses on the development of innovative drug substances that have the potential to improve therapeutic outcomes.
Latest Patents
Cortez holds a patent for an IL-7 drug substance, composition, preparation, and uses. This invention relates to new and improved interleukin-7 drug substances and corresponding specific immunoreactive antibodies. The patent also details methods for characterizing the impurity profile of recombinant IL-7 drug substances used for therapeutic purposes. The unexpected discovery that the long-term activity of recombinant IL-7 is primarily expressed by a specific conformer is a key aspect of this invention. It emphasizes the importance of minimizing product-related and process-related impurities that could trigger immune reactions against the desired IL-7 molecule. He has 1 patent to his name.
Career Highlights
Pierre Cortez is associated with Cytheris, a company dedicated to advancing immunological therapies. His work at Cytheris has positioned him as a key player in the development of innovative treatments that leverage the properties of interleukin-7.
Collaborations
Cortez has collaborated with notable colleagues, including Michel Christian Morre and Brigitte Assouline. These collaborations have contributed to the advancement of research in immunology and the development of new therapeutic strategies.
Conclusion
Pierre Cortez is a distinguished inventor whose work in immunology has the potential to transform therapeutic approaches. His innovative patent on IL-7 drug substances showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile